We had specific discussions around that issue. As I think you know, in November we were discussing issues related to trade and health.
This is a bit more of a long-term effort to try to make sure we have the ability to move WHO members in such a direction as to get rid of issues that are potential barriers, like customs procedures, limit the use of export restrictions—which goes directly to your point—eliminate tariffs and increase transparency. All this is with the objective of strengthening global supply chains and ensuring the free flow of essential medicines and medical supplies.
We're continuing to advance that initiative. The recent issues around export restrictions by the EU have complicated the EU's position on that particular issue, but we're continuing to push it forward.